Joseph Z. Forstot

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 612 citations · Full text

Autoimmune Disease, Systemic Scleroderma, Immunology +3

Cardiac complications of wegener granulomatosis: A case report of complete heart block and review of the literature

Joseph Z. Forstot, Paul Overlie, Gwynne K. Neufeld et al. · Seminars in Arthritis and Rheumatism · 1980 · 120 citations

Cardiac Complications, Wegener Granulomatosis, Pathology +4

Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study

Philip J. Mease, Nathan Wei, Edward J. Fudman et al. · The Journal of Rheumatology · 2009 · 109 citations · Full text

Sjogren's Syndrome and Polymyositis or Dermatomyositis

S. P. Ringel, Joseph Z. Forstot, Eng M. Tan et al. · Archives of Neurology · 1982 · 45 citations

The incidence of sjögren's sicca complex in a population of patients with keratoconjunctivitis sicca

Joseph Z. Forstot, S. Lance Forstot, Robert O. Greer et al. · Arthritis & Rheumatism · 1982 · 31 citations

Ocular Disease, Ophthalmology, Sjögren’s Syndrome +14